Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ovarian cancer diagnosis and treatment
TopicLeading institutions, researchers & key papers
This cluster of papers encompasses an extensive exploration of ovarian cancer, including genomic analyses, treatment strategies such as chemotherapy and cytoreductive surgery, identification of biomarkers, investigation of tumor models, mutation analysis, the role of fallopian tube origin in cancer development, metastasis patterns, and insights from clinical trials.
431
Works
IDs:OpenAlex
How has Ovarian cancer diagnosis and treatment's publication output changed over time?
ScholarIQpublication output · 2003–2019
Output grew50% over the shown period — from 2 works in 2003 to 3 in 2019.
2
1
1
3
1
1
1
1
1
3
2003200620102011201220132014201520162019
What are the most-cited papers on Ovarian cancer diagnosis and treatment?
ScholarIQmost cited works
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel, Helen Huang, Rebecca N. Baergen, Shashikant Lele, Larry J. Copeland, Joan L. Walker, Robert A. Burger
New England Journal of Medicine. 20062,636 CitationsOPEN ACCESS
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote, Claes G. Tropé, Frédéric Amant, Gunnar B. Kristensen, Tom Ehlen, Nick Johnson, René H.M. Verheijen, Maria E.L. van der Burg, Ángel J. Lacave, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Corneel Coens, Leen Verleye, Gavin Stuart, Sërgio Pecorelli, N.S. Reed
New England Journal of Medicine. 20102,539 CitationsOPEN ACCESS
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédèric Selle, Mansoor R. Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh Parmar, Amit M. Oza
New England Journal of Medicine. 20112,162 CitationsOPEN ACCESS
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen
Journal of Clinical Oncology. 20032,059 Citations
Where is Ovarian cancer diagnosis and treatment research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Ovarian cancer diagnosis and treatment is open access?
ScholarIQopen access share
80%OPEN ACCESS
Gold
7%
Green
20%
Hybrid
7%
Bronze
47%
Closed
20%
Related on ScholarIQ
Integrated genomic analyses of ovarian carcinoma
Paper
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Paper
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Paper
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Paper
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Paper
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Paper